Why the study?
Does peri-operative statin administration improve cardiac outcomes in patients with cardiovascular disease undergoing surgery?
Does peri-operative statin administration improve cardiac outcomes in patients with cardiovascular disease undergoing surgery?
Peri-operative statin administration may improve short- and long-term cardiac outcomes in patients with cardiovascular disease undergoing surgery, likely due to plaque stabilization.
May support peri-operative statin use in surgery; leaves open confirmation in dedicated RCTs.
Statin cardiovascular protection is mediated by lipid lowering and pleiotropic effects. The efficacy of statins has been established in non-surgical patients with cardiovascular disease and also more recently in non-surgical patients who sustain an acute coronary event. Peri-operative statin administration has been shown to improve both short-term and long-term cardiac outcome following non-cardiac and coronary bypass graft surgery. This cardioprotection may be independent of peri-operative haemodynamics due to a positive effect on plaque stability. Recommendations for the peri-operative statin administration are suggested. These include indications for peri-operative statin therapy, timing of administration, therapeutic targets, duration of administration, the adverse implications of peri-operative statin withdrawal, safety and cost-effectiveness.
No takes yet. Share an insight, caveat, or question.
Biccard et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: